CTGF expression is indicative of better survival rates in patients with medulloblastoma (2020)
Source: Cancer Gene Therapy. Unidade: FMRP
Subjects: MEDULOBLASTOMA, EXPRESSÃO GÊNICA
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. CTGF expression is indicative of better survival rates in patients with medulloblastoma. Cancer Gene Therapy, v. 27, n. 5, p. 378-382, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41417-019-0100-3. Acesso em: 14 ago. 2024.APA
Cruzeiro, G. A. V., Lira, R. C. P., Magalhães, T. de A., Scrideli, C. A., Valera, E. T., Baumgartner, M., & Tone, L. G. (2020). CTGF expression is indicative of better survival rates in patients with medulloblastoma. Cancer Gene Therapy, 27( 5), 378-382. doi:10.1038/s41417-019-0100-3NLM
Cruzeiro GAV, Lira RCP, Magalhães T de A, Scrideli CA, Valera ET, Baumgartner M, Tone LG. CTGF expression is indicative of better survival rates in patients with medulloblastoma [Internet]. Cancer Gene Therapy. 2020 ; 27( 5): 378-382.[citado 2024 ago. 14 ] Available from: https://doi.org/10.1038/s41417-019-0100-3Vancouver
Cruzeiro GAV, Lira RCP, Magalhães T de A, Scrideli CA, Valera ET, Baumgartner M, Tone LG. CTGF expression is indicative of better survival rates in patients with medulloblastoma [Internet]. Cancer Gene Therapy. 2020 ; 27( 5): 378-382.[citado 2024 ago. 14 ] Available from: https://doi.org/10.1038/s41417-019-0100-3